This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (23)  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in JAMA  Topic Collections  • Diabetes Mellitus  • Alert me on articles by topic

Michael Brownlee, MD; Irl B. Hirsch, MD

JAMA. 2006;295:1707-1708.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Diabetes affects an estimated 20.8 million individuals in the United States, 7% of the current population, and the lifetime risk of developing diabetes for those born in the year 2000 is 35%.^1-2 Many of these individuals will develop diabetes-specific microvascular pathology in the retina, renal glomerulus, and peripheral nerve and accelerated atherosclerotic macrovascular disease affecting arteries that supply the heart, brain, and lower extremities. In both type 1 and type 2 diabetes, large prospective clinical studies have shown a strong relationship between time-averaged mean levels of glycemia, measured as hemoglobin A_1c (HbA_1c), and diabetic complications.^3-4 These studies are the basis for the American Diabetes Association's current recommended treatment goal that HbA_1c should be less than 7%.⁵ However, only about a third of patients diagnosed as having diabetes achieve that goal.⁶ Even fewer reach the target level for HbA_1c of 6.5% advocated by . . . [Full Text of this Article]

Author Affiliations: JDRF International Center for Diabetic Complications Research, Albert Einstein College of Medicine, Bronx, NY (Dr Brownlee); and University of Washington School of Medicine, Diabetes Care Center, Seattle (Dr Hirsch).

RELATED ARTICLES

Activation of Oxidative Stress by Acute Glucose Fluctuations Compared With Sustained Chronic Hyperglycemia in Patients With Type 2 Diabetes
Louis Monnier, Emilie Mas, Christine Ginet, Françoise Michel, Laetitia Villon, Jean-Paul Cristol, and Claude Colette
JAMA. 2006;295(14):1681-1687.
ABSTRACT | FULL TEXT  

Assessing Glycemia in Diabetes Using Self-monitoring Blood Glucose and Hemoglobin A_1c
Christopher D. Saudek, Rachel L. Derr, and Rita R. Kalyani
JAMA. 2006;295(14):1688-1697.
ABSTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Effect of Glycemic Exposure on the Risk of Microvascular Complications in the Diabetes Control and Complications Trial--Revisited
Lachin et al.
Diabetes 2008;57:995-1001.
ABSTRACT | FULL TEXT  

Renal complications of childhood type 1 diabetes
Carel and Levy-Marchal
BMJ 2008;336:677-678.
FULL TEXT  

Self-Monitoring of Blood Glucose Before and After Medicare Expansion Among Medicare Beneficiaries With Diabetes Who Do Not Use Insulin
Li et al.
Am. J. Public Health 2008;98:358-364.
ABSTRACT | FULL TEXT  

Dietary Strategies for Improving Post-Prandial Glucose, Lipids, Inflammation, and Cardiovascular Health
O'Keefe et al.
J Am Coll Cardiol 2008;51:249-255.
ABSTRACT | FULL TEXT  

Influence of Mulberry Leaf Extract on the Blood Glucose and Breath Hydrogen Response to Ingestion of 75 g Sucrose by Type 2 Diabetic and Control Subjects
Mudra et al.
Diabetes Care 2007;30:1272-1274.
FULL TEXT  

Glucose Fluctuations and Oxidative Stress--Reply
Monnier et al.
JAMA 2006;296:1730-1731.
FULL TEXT